BioNTech SE

Healthcare · Biotechnology

99.10$ +0.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

BioNTech SE (BNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 20,334 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BNTX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	22,207	23,006	22,257	22,238	22,401	22,530	21,182	21,638	21,341	21,979	21,096	20,334
Current Assets	18,749	19,527	18,274	18,282	18,486	18,804	15,626	15,929	15,831	16,140	15,548	15,291
Cash	13,496	11,664	8,977	10,377	9,625	9,762	10,185	10,270	10,093	7,672	9,950	9,737
Cash & Short-Term Investments	15,749	16,549	15,667	17,296	16,709	16,784	14,110	14,037	14,528	14,834	14,652	9,737
Receivables	2,009	2,161	1,925	287	1,198	1,524	1,027	1,447	700	984	613	245
Inventory	416	358	345	340	303	283	254	231	226	111	104	101
Property, Plant & Equipment	926	–	–	–	–	–	–	–	–	–	–	–
Goodwill	366	363	369	372	374	381	376	364	358	368	371	373
Intangible Assets	666	782	822	862	874	790	1,511	1,487	1,390	1,605	1,548	1,421
Total Liabilities	2,340	2,760	2,289	3,166	3,287	3,119	2,256	3,133	2,864	2,763	2,379	2,584
Current Liabilities	1,807	2,071	1,606	2,426	2,523	2,523	1,535	1,851	2,223	2,141	1,767	1,948
Short-Term Debt	40	28	31	35	37	40	56	52	53	52	57	57
Accounts Payable	223	354	299	882	763	427	444	504	400	535	469	646
Long-Term Debt	162	191	205	219	206	215	238	217	192	215	246	259
Shareholders' Equity	19,867	20,246	19,968	19,072	19,115	19,411	18,927	18,505	18,477	19,216	18,717	17,750
Retained Earnings	19,305	19,763	19,448	18,640	18,839	19,098	18,682	18,296	18,267	17,954	17,448	16,602
Shares Outstanding	240	241	241	238	245	240	240	242	239	245	253	253

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings